Moderna Plunges as Sales View Disappoints, Research Budget Cut

Moderna Plunges As Sales View Disappoints, Research Budget Cut

2 weeks from now

Sep 12, 2024  · Moderna Inc. said it aims to reduce its research and development budget by about 20% over the next three years as it tries to find a path to profitability following disappointing …

bloomberg.com

Moderna Cuts 2025 Sales Forecast By $1 Bln On Weak Vaccine …

2 weeks from now

Jan 13, 2025  · Shares plunge more than 24% in early trading 2025 revenue forecast misses expectations, prior view CEO Bancel says to reduce 2025 cash costs by $1 bln Jan 13 …

reuters.com

Moderna Plunges As Sales View Disappoints, Research Budget Cut

2 weeks from now

Moderna Inc. said it aims to reduce its research and development budget by about 20% over the next three years as it tries to find a path to profitability following disappointing vaccine sales. …

bloomberglaw.com

Moderna Cuts 2025 Sales Forecast By $1 Billion On Weak Vaccine …

2 weeks from now

Jan 13, 2025  · (Reuters) -Moderna (MRNA) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for …

yahoo.com

Moderna Crashes After Slashing Its R&D Budget By $1.1 Billion

2 weeks from now

Sep 16, 2024  · Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget by $1.1 billion and issued light 2025 sales guidance. The company says its investment …

investors.com

Moderna Stock Plunges Nearly 20% As Company Reports Poor …

2 weeks from now

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development (R&D) budget by about 20% over the next three years, a result of low sales …

msn.com

Moderna Shares Plunge On Plans To Cut $1.1 Billion In Costs, Launch …

2 weeks from now

Sep 12, 2024  · Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.

cnbc.com

Moderna Stock Plummets 17% On 2025 Sales Guidance Slash

2 weeks from now

Jan 14, 2025  · Moderna reduced its previously announced sales guidance for 2025 by $1 billion. It now forecasts total revenues in the range of $1.5 to $2.5 billion, mainly from product sales of …

yahoo.com

Moderna Shares Plunge As Sales View Disappoints - MSN

2 weeks from now

Moderna shares plunge as sales view disappoints 6d M oderna said it aimed to reduce its research and development budget by about 20% over the next three years as it tries to find a …

msn.com

Moderna's Pain Continues As Downgrades Mount Post R&D Day

2 weeks from now

Sep 16, 2024  · Moderna said Thursday it plans to slash its research and development budget by $1.1 billion in 2027 as it focuses on launching 10 new products over the next three years.

investors.com

Moderna Stock Plunges After Vaccine Sales Struggle - The Wall …

2 weeks from now

Jan 13, 2025  · In comparison, Moderna expects to report product sales of up to $3.1 billion for 2024. The company is speeding up planned cost cuts, and now sees reducing cash costs by …

wsj.com

Moderna Will Cut $1.1bn Off Its Annual R&D Spend

2 weeks from now

Jan 27, 2025  · Moderna says it will cut $1.1bn off its annual R ... Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in …

pharmaphorum.com

Moderna's Spending Cuts, Pipeline Shakeup Leave Doubts About A …

2 weeks from now

Sep 13, 2024  · The J.P. Morgan analysts downgraded Moderna's stock to underweight from neutral, and cut their price target to $70, from $88. Moderna's stock is down 33% in the year to …

morningstar.com

Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut

2 weeks from now

Sep 13, 2024  · Shares of Moderna fell Friday after taking on steep losses a day earlier on the news that it plans to cut research and development spending by $1.1 billion by 2027.

investopedia.com

Moderna Provides Business And Pipeline Updates At 43rd Annual …

2 weeks from now

Jan 13, 2025  · 2025 financial framework: Moderna is accelerating and expanding its previous cost efficiency and prioritization programs and now projects cash cost reductions of $1.0 billion …

modernatx.com